Results 361 to 370 of about 1,686,692 (405)
Some of the next articles are maybe not open access.
Experimental and Molecular Therapeutics, 2019
Activating mutations in RAS represent the most common oncogenic driver mutation in cancer. The single amino acid substitution of cysteine for glycine at position 12 (KRASG12C) is frequently found in solid malignancies, particularly in lung adenocarcinoma
A. Y. Saiki +13 more
semanticscholar +1 more source
Activating mutations in RAS represent the most common oncogenic driver mutation in cancer. The single amino acid substitution of cysteine for glycine at position 12 (KRASG12C) is frequently found in solid malignancies, particularly in lung adenocarcinoma
A. Y. Saiki +13 more
semanticscholar +1 more source
Journal of Adhesion Science and Technology, 2019
In this work, nylon 6/66 and nylon 6/66/510 containing 5 ∼ 20 mol % nylon-510 were synthesized to be used as hot melt adhesive for metal plate with low-surface-energy coating.
Weilan Xue +3 more
semanticscholar +1 more source
In this work, nylon 6/66 and nylon 6/66/510 containing 5 ∼ 20 mol % nylon-510 were synthesized to be used as hot melt adhesive for metal plate with low-surface-energy coating.
Weilan Xue +3 more
semanticscholar +1 more source
1996
Prior to marketing a device in the United States, manufacturers or initial distributors of imported devices must obtain Food and Drug Administration (FDA) marketing clearance. There are two routes to the market: premarket notification [510(k)] and premarket approval(PMA).
openaire +2 more sources
Prior to marketing a device in the United States, manufacturers or initial distributors of imported devices must obtain Food and Drug Administration (FDA) marketing clearance. There are two routes to the market: premarket notification [510(k)] and premarket approval(PMA).
openaire +2 more sources
Journal of Cellular Biochemistry, 2018
MicroRNAs (miRNAs) have been found to play an important role in the regulation of gene expression in eukaryotic organisms at the posttranscriptional level. More than half of miRNA genes have been recognized to be located in different fragile sites. Among
Z. Fazeli +3 more
semanticscholar +1 more source
MicroRNAs (miRNAs) have been found to play an important role in the regulation of gene expression in eukaryotic organisms at the posttranscriptional level. More than half of miRNA genes have been recognized to be located in different fragile sites. Among
Z. Fazeli +3 more
semanticscholar +1 more source
Perspectives on the Hud “510” Rehabilitation Demonstration
Journal of Urban Affairs, 1980The 510 Demonstration program in New York City is designed to reveal if the rehabilitation of vacant buildings under the Section 8 HUD program, coupled with the moderate rehabilitation and conversion to cooperatives of substantially occupied “sibling” buildings, can create a strong sense of occupant control and social cohesion.
openaire +2 more sources
, 2015
Probing the product selectivity of Fischer–Tropsch catalysts is of prime scientific and industrial importance—with the aim to upgrade products and meet various end-use applications.
T. Pham +7 more
semanticscholar +1 more source
Probing the product selectivity of Fischer–Tropsch catalysts is of prime scientific and industrial importance—with the aim to upgrade products and meet various end-use applications.
T. Pham +7 more
semanticscholar +1 more source
High speed querying with the DAP 510
Proceedings ICCI `92: Fourth International Conference on Computing and Information, 2003Most database queries can be reduced to a few distinct classes of requests. These are (1) finding the k/sup th/ smallest element in an unordered set S, (2) finding the k/sup th/ through the (k+i)/sup th/ smallest elements in an unordered set S, and (3) return the record with a specific key.
openaire +2 more sources
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Nature, 2019J. Canon +36 more
semanticscholar +1 more source
Malrotation of the McGhan Style 510 Prosthesis
Plastic and Reconstructive Surgery, 2011Curinga, Giuseppe +3 more
openaire +3 more sources
Technology evaluation: ABT-510, Abbott.
Current opinion in molecular therapeutics, 2004ABT-510 is a small peptide thrombospondin-1 mimetic angiogenesis inhibitor under development by Abbott Laboratories for the potential treatment of solid tumors. ABT-510 is undergoing phase II clinical trials.
openaire +2 more sources